1. Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases. Issue 7 (24th July 2019) Authors: Gafer, Huda; de Waard, Quincy; Compter, Annette; van den Heuvel, Michel Journal: BMJ case reports Issue: Volume 12:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗